Sal

India Founded: 2019 • Age: 7 yrs
Provider drug development and manufacturing tools and services for the healthcare industry

About Sal

Sal is a Healthcare company based in India founded in 2019. Provider drug development and manufacturing tools and services for the healthcare industry. Its Indian entity Sal Biosciences Private Limited reported revenue of β‚Ή2.9 Lakh. Its focus areas include HealthTech, Life Sciences Tech, Manufacturing and Life Sciences.

Company details

Sal was founded in 2019 and is based in India. Tools and services for drug development and manufacturing are supplied to the healthcare sector. Processes for drug development and marketing are managed through offered solutions. Drug regulation, upstream process optimization, and supply chain management are supported by key features. Operations focus on healthcare industry needs in a regulated environment.

Key Metrics
  • Annual Revenue
    ₹2.9 Lakh

    FY 2025 · +20384% YoY

  • Net Loss
    -₹9 Lakh

    FY 2025 · -315% margin

  • EBITDA
    -₹11.5 Lakh

    FY 2025 · -401% margin

Board of directors of Sal Biosciences Private Limited (Sal)

Sal Biosciences Private Limited is the primary company behind Sal. The board of Sal Biosciences Private Limited currently have 5 directors; the longest-serving is Sumanth Muralidhar, appointed in 2019.

DirectorDesignationAppointedTenureEntity
Sumanth Muralidhar
DIN 08318243
Director02 Jan 20197 yrs 9 moSal Biosciences Private Limited
Muralidhar Sharath Vasista
DIN 08318244
Director02 Jan 20197 yrs 9 moSal Biosciences Private Limited
Venkatesh Ramaswamy
DIN 10486933
Additional Director01 Feb 20242 yrs 8 moSal Biosciences Private Limited
Bangalore Govindaiah Ashiq
DIN 10486929
Additional Director01 Feb 20242 yrs 8 moSal Biosciences Private Limited
Anil Kumar Hanumanthaiah
DIN 07867492
Additional Director01 Feb 20242 yrs 8 moSal Biosciences Private Limited

Financials of Sal

Figures of Sal Biosciences Private Limited, the primary company behind Sal, for FY 2025. Revenue was ₹2.9 Lakh (+20384% year on year). Net loss was -₹9 Lakh (-315% margin). EBITDA was -₹11.5 Lakh (-401% margin). Revenue has grown at a compounded annual rate of -27% over three years and -36% over five years.

  • ₹2.9 LakhRevenue · FY 2025 · +20384% YoY
  • -₹9 LakhNet loss · -315% margin
  • -₹11.5 LakhEBITDA · -401% margin
  • ₹3 LakhPaid-up capital
  • -27%Revenue CAGR, 3 years
  • -36%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Sal Biosciences Private Limited are on its company page.

Premium access

Detailed financial statements for Sal

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Sal

Sal was founded in 2019.

Sal is headquartered in India.

The primary company behind Sal, Sal Biosciences Private Limited, reported revenue of β‚Ή2.9 Lakh for FY 2025, up 20384% year on year.

Sal was founded in 2019 and is based in India. Tools and services for drug development and manufacturing are supplied to the healthcare sector. Processes for drug development and marketing are managed through offered solutions. Drug regulation, upstream process optimization, and supply chain management are supported by key features. Operations focus on healthcare industry needs in a regulated environment.

Sal operates through Sal Biosciences Private Limited.

The legal entities of Sal currently have 5 directors, including Sumanth Muralidhar, Muralidhar Sharath Vasista, Venkatesh Ramaswamy and others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available